Skip to main content

Vaginal Hysterectomy

Vaginal hysterectomy (VH) is the preferred minimally invasive route for hysterectomy whenever feasible (ACOG Committee Opinion 701). The uterus is removed entirely through the vagina without an abdominal incision; recovery is faster, hospital stay shorter, and wound infections fewer than with abdominal hysterectomy. In the prolapse setting, VH is the standard surgical treatment for symptomatic uterine prolapse when the patient does not desire uterine preservation, and must be combined with a concomitant apical support repair (McCall culdoplasty, USLS, or SSLF) — hysterectomy without apical suspension is inadequate (Level B).[1][2]

For uterus-preserving alternatives, see Sacrospinous Hysteropexy and Manchester-Fothergill Procedure. For the apical adjuncts performed at the same setting, see McCall Culdoplasty, Uterosacral Ligament Suspension, and Sacrospinous Ligament Fixation. For the broader prolapse decision framework, see Prolapse Repair.

Indications​

VH is most commonly performed for benign disease. Approximately 590,000 hysterectomies are performed annually in the United States; the most common indications are abnormal uterine bleeding, prolapse, and fibroids.[2]

  • Symptomatic uterine prolapse when uterine preservation is not desired — the classic, most straightforward indication. Always pair with an apical suspension (Level B).[1]
  • Abnormal uterine bleeding refractory to medical management.
  • Uterine leiomyomata, particularly when uterine size is not prohibitively large.
  • Cervical dysplasia (selected cases).
  • Endometrial hyperplasia without atypia.

Patient Selection and Feasibility​

Key factors determining candidacy:[1]

FactorConsideration
Uterine size and mobilityAdequate descent or sufficient mobility after dividing uterosacral and cardinal ligaments
Vaginal accessibilityAdequate caliber for instrumentation
Pathology confined to uterusAbsence of significant adnexal pathology, severe endometriosis, or dense adhesions
Prior surgeryPrior cesarean delivery and nulliparity are not absolute contraindications; 92% of VH planned in women with no prior vaginal deliveries were successfully completed vaginally[1]

A systematic review found no patient characteristics that absolutely preclude a vaginal approach.[3] Significant extrauterine disease (severe endometriosis, dense adhesions, markedly enlarged uterus) may preclude VH; laparoscopic assistance can extend feasibility.[1]

Surgical Technique​

  1. Positioning and prep. Dorsal lithotomy; bladder drainage; vaginal antisepsis with chlorhexidine or povidone-iodine.[3]
  2. Circumferential cervicovaginal incision.[4]
  3. Anterior cul-de-sac entry. Sharp dissection into the vesicocervical space; identification and sharp entry of the peritoneal reflection. Confirm correct entry by visualizing small bowel or omental fat. In difficult cases (procidentia, cervical elongation, prior cesarean section), useful adjuncts include cystoscopic bladder illumination, posterior entry first, or extraperitoneal pedicle ligation before completing anterior entry.[4]
  4. Posterior cul-de-sac entry. Sharp entry into the pouch of Douglas.
  5. Sequential pedicle ligation. Uterosacral ligaments → cardinal ligaments → uterine vessels → upper pedicles (round ligaments and utero-ovarian or infundibulopelvic ligaments).
  6. Uterine removal. Delivered through the vagina. Morcellation (bisection, wedging, coring, or intramyometrial techniques) is required in approximately 11% of cases for larger uteri.[1]
  7. Vaginal cuff closure. Vertical cuff closure results in approximately 1 cm greater vaginal length than horizontal closure. Either peritoneum or vaginal epithelium can be used for colpotomy closure.[3]
  8. Apical support — mandatory for prolapse cases. McCall culdoplasty, USLS, or SSLF performed at the same setting; hysterectomy alone for prolapse is inadequate.[1]

Intraoperative adjuncts[3]​

  • Vasopressin injection — decreases blood loss by ~130 mL.
  • Tissue-sealing devices (LigaSure, BiClamp) — reduce blood loss (~44 mL) and operative time (~15 min) vs suture ligation; see Vessel Sealing vs Suture Ligation below.[3]
  • Routine vaginal packing is not advised postoperatively.

Vessel Sealing vs Suture Ligation​

Energy-based vessel sealing is a well-supported alternative to suture ligation for securing the vascular pedicles (uterosacral, cardinal, uterine, and utero-ovarian), reducing operative time and blood loss without raising complication rates.[15][3]

Traditional suture ligation​

The clamp-cut-ligate technique — sequentially clamping, dividing, and suture-ligating each pedicle — remains the foundational method and the comparator for every device study. It gives reliable hemostasis but is slower, needs working room for knot-tying in the confined vaginal field, and uses more suture (median ~7 ligatures/case); it also demands the vaginal-suturing proficiency that is hardest exactly where access is worst — the non-prolapsed uterus, obesity, nulliparity.[13]

Energy devices​

  • Bipolar vessel sealers (LigaSure, BiClamp) — controlled bipolar RF energy plus jaw pressure denature vessel-wall collagen and elastin into a permanent seal; this is where the evidence is strongest.[14][16]
  • Ultrasonic shears (Harmonic) — high-frequency mechanical vibration to cut and coagulate; the evidence in VH is weaker, with one RCT showing less blood loss but no meaningful operative-time benefit.[17]

Evidence​

  • Kroft & Selk meta-analysis (7 RCTs, 662 patients): energy sealing cut operative time by 17.2 min (95% CI 7.5–27.0) and blood loss by 47.7 mL (15.5–79.9), with a smaller Hb drop (~0.3 g/dL) and shorter stay (~0.25 d), and no increase in complications.[14]
  • Bonavina network meta-analysis (17 studies, 1,577 women): both LigaSure and BiClamp reduced blood loss vs suture; LigaSure additionally reduced operative time, postoperative Hb variation, and pain, with comparable intraoperative-complication rates.[16]
  • ACOG systematic review (Jeppson): sealing devices decrease blood loss by ~44 mL and operative time by ~15 min, with uncertain implications for complications.[3]

Practical points​

  • The advantage is greatest in difficult cases — non-prolapsed or larger uteri, limited vaginal access — where pedicle-securing time dominates.[18]
  • Devices cut the ligature count from ~7 to ~1, simplifying the confined field.[13]
  • Two device-specific hazards: inadequate sealing (tissue too thick, wet, or poorly grasped) and thermal injury to the ureter, bladder, or bowel — mitigated by full jaw closure, avoiding bulky tissue bundles, and respecting thermal spread.[19]
  • Disposable cost offsets some or all of the time/stay savings.
  • Suture ligation is still required for vaginal-cuff closure and apical suspension regardless of how the pedicles are taken.

Concurrent Procedures​

  • Opportunistic salpingectomy can usually be safely accomplished at VH and should not alter the intended route.[1][2]
  • Bilateral salpingo-oophorectomy (BSO) completion at VH ranges 65–97.5%.[1]
  • Pelvic-floor repair — anterior / posterior colporrhaphy and apical suspension are commonly performed concurrently in prolapse cases.

Outcomes vs Other Routes​

OutcomeVH vs AbdominalVH vs LaparoscopicSource
Return to normal activities~12 days shorter with VHNo significant difference[1]
Hospital stay~1–1.6 days shorter with VHSimilar / shorter with VH[1][2]
Operative timeShorter with VHShorter with VH (~110 vs 137 min)[2][3]
Wound / abdominal-wall infection1% vs 6% — significantly lower with VHN/A (no abdominal incision)[1]
Urinary tract injuryNo clear differenceNo clear difference (~1% each)[1]
Vaginal cuff dehiscence0.08% (lowest of all routes)Higher with laparoscopic (1.35%)[6]
Blood transfusionLower with VHHigher with VH in some large cohorts[3][5]

Contemporary re-evaluation​

A large 2026 NSQIP analysis of 83,436 propensity-matched patients found low overall complication rates for both VH and laparoscopic hysterectomy (8.2% vs 6.4%). VH carried slightly higher rates of transfusion, UTI, and reoperation; laparoscopic hysterectomy carried higher rates of wound dehiscence and pulmonary embolism. The authors concluded VH is not clearly superior to laparoscopic hysterectomy in contemporary practice — the traditional preference may warrant re-evaluation.[5]

The Danish Hysterectomy Database (n = 51,141) similarly found that laparoscopic hysterectomy had fewer major complications than VH for non-prolapse indications (RR 0.78), particularly in 2010–2015 as laparoscopic expertise matured.[7]

Complications​

Overall VH complication rates are among the lowest of all hysterectomy routes:[8]

DomainRate
Major complications2.6–4.9% (lower for prolapse indications)[7][8]
Total complications~11.7%[8]
Estimated blood loss215–287 mL; transfusion uncommon[6]
Bladder injury~1%; risk prior cesarean OR 4.01, uterus ≥ 500 g OR 2.88[8][9]
Ureteral injury~0.3%; VH has the lowest GU-injury rate vs abdominal (OR 0.56)[9]
UTIMost common VH-specific complication[2]
Vaginal cuff infectionSlightly more common than abdominal hysterectomy (limited data)[2]
Vaginal cuff dehiscence0.08% — lowest of all routes[6]
Neuropathy0.2–2% after major pelvic surgery[6]
VTELess common after VH than after laparoscopic hysterectomy[5]

Perioperative Care​

ElementRecommendation
Antibiotic prophylaxisSingle-dose cefazolin for all hysterectomy routes (>30 RCTs, 4 meta-analyses)[10]
ERAS analgesiaMultimodal — scheduled acetaminophen, NSAIDs, gabapentin to minimize opioids; paracervical nerve block or intrathecal morphine specifically for VH[11]
VTE prophylaxisEarly ambulation, intermittent pneumatic compression, compression stockings; pharmacologic prophylaxis based on VTE risk stratification[11]
RecoveryReturn to normal activities 24–38 days after VH vs ~42 days after abdominal hysterectomy; multidisciplinary consensus recommends graded resumption of activities[2][12]

ACOG Guidance (Committee Opinion 701)[1]​

  • VH is the approach of choice whenever feasible.
  • Laparoscopic hysterectomy is the preferred alternative when VH is not feasible.
  • Nulliparity and prior cesarean delivery are not contraindications.
  • Opportunistic salpingectomy should not change the planned route.
  • Surgeon training, experience, and case volume should factor into route selection.

Key Principles​

  • VH is the preferred minimally invasive route for hysterectomy whenever feasible (ACOG CO 701).[1]
  • For prolapse, VH alone is inadequate — pair with apical suspension (McCall culdoplasty, USLS, or SSLF).[1]
  • No patient characteristics absolutely preclude a vaginal approach; nulliparity and prior cesarean are not contraindications (92% completion in no-prior-vaginal-delivery cohorts).[1][3]
  • Vasopressin and tissue-sealing devices reduce blood loss and operative time.[3]
  • Vertical cuff closure preserves ~1 cm more vaginal length than horizontal.[3]
  • Bladder injury rises with prior cesarean (OR 4.01) and uterus ≥ 500 g (OR 2.88) — counsel and prepare accordingly.[9]
  • VH has the lowest cuff dehiscence rate of all routes (0.08%).[6]
  • Contemporary data (NSQIP 2026, Danish Database) suggest laparoscopic hysterectomy may match or exceed VH in non-prolapse indications — surgeon experience and case mix matter.[5][7]
  • Opportunistic salpingectomy should not change route; perform at VH when feasible.[1][2]

Videos​

Vaginal Hysterectomy: Teaching Video
Urogynecology for Beginners (2024)
Total Vaginal Hysterectomy
Steven McCarus, J&J MedTech (2024)

References​

1. Committee on Gynecologic Practice. Committee Opinion No. 701: Choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017;129(6):e155-e159. doi:10.1097/AOG.0000000000002112.

2. Pickett CM, Seeratan DD, Mol BWJ, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2023;8:CD003677. doi:10.1002/14651858.CD003677.pub6.

3. Jeppson PC, Balgobin S, Rahn DD, et al. Comparison of vaginal hysterectomy techniques and interventions for benign indications: a systematic review. Obstet Gynecol. 2017;129(5):877-886. doi:10.1097/AOG.0000000000001995.

4. Linder BJ, Gebhart JB. Entry into the anterior cul-de-sac during vaginal hysterectomy. Int Urogynecol J. 2018;29(8):1223-1225. doi:10.1007/s00192-018-3646-y.

5. Meyer R, Hamilton KM, Ezike O, et al. Vaginal hysterectomy vs laparoscopic hysterectomy for benign indications: complications and length of stay in a national analysis of contemporary data. Am J Obstet Gynecol. 2026;234(3):620-631. doi:10.1016/j.ajog.2025.10.027.

6. Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654-673. doi:10.1097/AOG.0b013e3182841594.

7. Settnes A, Moeller C, Topsoee MF, et al. Complications after benign hysterectomy, according to procedure: a population-based prospective cohort study from the Danish Hysterectomy Database, 2004-2015. BJOG. 2020;127(10):1269-1279. doi:10.1111/1471-0528.16200.

8. Brummer TH, Jalkanen J, Fraser J, et al. FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors. Hum Reprod. 2011;26(7):1741-51. doi:10.1093/humrep/der116.

9. Dallas KB, Rogo-Gupta L, Elliott CS. Urologic injury and fistula after hysterectomy for benign indications. Obstet Gynecol. 2019;134(2):241-249. doi:10.1097/AOG.0000000000003353.

10. Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 195: Prevention of infection after gynecologic procedures. Obstet Gynecol. 2018;131(6):e172-e189. doi:10.1097/AOG.0000000000002670.

11. Committee on Gynecologic Practice. ACOG Committee Opinion No. 750: Perioperative pathways: enhanced recovery after surgery. Obstet Gynecol. 2018;132(3):e120-e130. doi:10.1097/AOG.0000000000002818.

12. Vonk Noordegraaf A, Huirne JA, Brölmann HA, van Mechelen W, Anema JR. Multidisciplinary convalescence recommendations after gynaecological surgery: a modified Delphi method among experts. BJOG. 2011;118(13):1557-67. doi:10.1111/j.1471-0528.2011.03091.x.

13. Cronjé HS, de Coning EC. Electrosurgical bipolar vessel sealing during vaginal hysterectomy. Int J Gynaecol Obstet. 2005;91(3):243-245. doi:10.1016/j.ijgo.2005.08.019.

14. Kroft J, Selk A. Energy-based vessel sealing in vaginal hysterectomy: a systematic review and meta-analysis. Obstet Gynecol. 2011;118(5):1127-1136. doi:10.1097/AOG.0b013e3182324306.

15. Hefni MA, Bhaumik J, El-Toukhy T, et al. Safety and efficacy of using the LigaSure vessel sealing system for securing the pedicles in vaginal hysterectomy: randomised controlled trial. BJOG. 2005;112(3):329-333. doi:10.1111/j.1471-0528.2004.00325.x.

16. Bonavina G, Bonitta G, Busnelli A, et al. Vaginal hysterectomy: a network meta-analysis comparing short-term outcomes of surgical techniques and devices. J Minim Invasive Gynecol. 2024;31(10):825-835. doi:10.1016/j.jmig.2024.07.013.

17. Fitz-Gerald AL, Tan J, Chan KW, et al. Comparison of ultrasonic shears and traditional suture ligature for vaginal hysterectomy: randomized controlled trial. J Minim Invasive Gynecol. 2013;20(6):853-857. doi:10.1016/j.jmig.2013.05.019.

18. Elhao M, Abdallah K, Serag I, El-Laithy M, Agur W. Efficacy of using electrosurgical bipolar vessel sealing during vaginal hysterectomy in patients with different degrees of operative difficulty: a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):86-90. doi:10.1016/j.ejogrb.2009.07.011.

19. Davidson ERW, Kho R. Use of vessel-sealing devices during vaginal hysterectomy. J Minim Invasive Gynecol. 2019;26(2):362. doi:10.1016/j.jmig.2018.04.018.